ALOPECIA, ANDROGENETIC

Clinical trials for ALOPECIA, ANDROGENETIC explained in plain language.

Never miss a new study

Get alerted when new ALOPECIA, ANDROGENETIC trials appear

Sign up with your email to follow new studies for ALOPECIA, ANDROGENETIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New hair loss drug enters final testing phase

Disease control Not yet recruiting

This study tests a new medicine called APSMNF for male pattern baldness. About 336 men aged 18 to 60 will take the drug or a placebo to see if it increases hair density and is safe. The trial is not yet recruiting.

Matched conditions: ALOPECIA, ANDROGENETIC

Phase: PHASE3 • Sponsor: Apsen Farmaceutica S.A. • Aim: Disease control

Last updated May 18, 2026 12:04 UTC

ALOPECIA, ANDROGENETIC

Get alerted when new ALOPECIA, ANDROGENETIC trials appear

New hair loss drug enters final testing phase